Skip to main content

Advertisement

Log in

Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia

  • Original Article
  • Published:
Mediterranean Journal of Nutrition and Metabolism

An Erratum to this article was published on 26 October 2010

Abstract

The aim of the present study was to test the efficacy and safety of an oral amino acid functional cluster (AFC) supplementation in cachectic cancer patients. From April 2008 to March 2009, we carried out an open non-randomized phase II study on 25 cachectic advanced (all stage IV) cancer patients with tumor at different sites who received an oral AFC supplementation for 8 weeks. Efficacy was assessed on the basis of improvement of some nutritional/functional (weight, body mass index, lean body mass and grip strength), quality of life (fatigue) and laboratory (albumin, fibrinogen, C-reactive protein, proinflammatory cytokines, leptin and reactive oxygen species) variables. Safety was evaluated according to the NCI-CTCAE version 3. Patients supplemented with the AFC achieved an increase in grip strength (P < 0.0001) and total serum albumin (P = 0.0003) and a decrease in ROS levels (P = 0.001). Moreover, our study showed a trend toward an increase in body weight and leptin and a decrease in CRP and IL-6. In conclusion, the results of the present study suggest that amino acid supplementation may be a significant rational tool for the treatment of cancer cachexia. Our preliminary data should be confirmed in a larger sample size and by a properly designed randomized clinical trial. According to our longstanding experience, a potential area of further research may be to integrate amino acid supplementation into a multi-dimensional approach based on diet, nutritional support and molecularly targeted drugs for the management of cancer cachexia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. National Cancer Institute—Cancer Therapy Evaluation Program: Common Terminology Criteria for Adverse Events v3.0 (CTCAE), 9 August 2006

  2. NIH guide. Cachexia: research into biobehavioral management and quality of life, 11 June 2001

  3. Argiles JM (2005) Cancer-associated malnutrition. Eur J Oncol Nurs 9(Suppl 2):S39–S50

    Article  Google Scholar 

  4. Argiles JM, Alvarez B, Carbo N, Busquets S, Van Royen M, Lopez-Soriano FJ (2000) The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting. Eur Cytokine Netw 11:552–559

    CAS  Google Scholar 

  5. Baracos VE, Mackenzie ML (2006) Investigations of branched-chain amino acids and their metabolites in animal models of cancer. J Nutr 136:237S–242S

    CAS  Google Scholar 

  6. Bartfay WJ, Davis MT, Medves JM, Lugowski S (2003) Milk whey protein decreases oxygen free radical production in a murine model of chronic iron-overload cardiomyopathy. Can J Cardiol 19:1163–1168

    CAS  Google Scholar 

  7. Baumgartner RN, Koehler KM, Romero L, Garry PJ (1996) Serum albumin is associated with skeletal muscle in elderly men and women. Am J Clin Nutr 64:552–558

    CAS  Google Scholar 

  8. Berk L, James J, Schwartz A et al (2008) A randomized, double-blind, placebo-controlled trial of a beta-hydroxyl beta-methyl butyrate, glutamine, and arginine mixture for the treatment of cancer cachexia (RTOG 0122). Support Care Cancer 16:1179–1188

    Article  Google Scholar 

  9. Bossola M, Pacelli F, Tortorelli A, Doglietto GB (2007) Cancer cachexia: it’s time for more clinical trials. Ann Surg Oncol 14:276–285

    Article  Google Scholar 

  10. Bruera E (1997) ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 315:1219–1222

    CAS  Google Scholar 

  11. Cangiano C, Laviano A, Meguid MM et al (1996) Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients. J Natl Cancer Inst 88:550–552

    Article  CAS  Google Scholar 

  12. Clark RH, Feleke G, Din M et al (2000) Nutritional treatment for acquired immunodeficiency virus-associated wasting using beta-hydroxy beta-methylbutyrate, glutamine, and arginine: a randomized, double-blind, placebo-controlled study. J Parenter Enteral Nutr 24:133–139

    Article  CAS  Google Scholar 

  13. Dioguardi FS (2004) Wasting and the substrate-to-energy controlled pathway: a role for insulin resistance and amino acids. Am J Cardiol 93:6A–12A

    Article  CAS  Google Scholar 

  14. Droge W (2005) Oxidative stress and ageing: is ageing a cysteine deficiency syndrome? Philos Trans R Soc Lond B Biol Sci 360:2355–2372

    Article  Google Scholar 

  15. Drummond MJ, Dreyer HC, Fry CS, Glynn EL, Rasmussen BB (2009) Nutritional and contractile regulation of human skeletal muscle protein synthesis and mTORC1 signaling. J Appl Physiol 106:1374–1384

    Article  CAS  Google Scholar 

  16. Giordano M, Castellino P, DeFronzo RA (1996) Differential responsiveness of protein synthesis and degradation to amino acid availability in humans. Diabetes 45:393–399

    Article  CAS  Google Scholar 

  17. Hack V, Breitkreutz R, Kinscherf R et al (1998) The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 92:59–67

    CAS  Google Scholar 

  18. Hauer K, Hildebrandt W, Sehl Y, Edler L, Oster P, Droge W (2003) Improvement in muscular performance and decrease in tumor necrosis factor level in old age after antioxidant treatment. J Mol Med 81:118–125

    CAS  Google Scholar 

  19. Inui A (2002) Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72–91

    Article  Google Scholar 

  20. Kuwata K, Era S, Sogami M (1994) The kinetic studies on the intramolecular SH, S–S exchange reaction of bovine mercaptalbumin. Biochim Biophys Acta 1205:317–324

    CAS  Google Scholar 

  21. Lands LC, Grey VL, Smountas AA (1999) Effect of supplementation with a cysteine donor on muscular performance. J Appl Physiol 87:1381–1385

    CAS  Google Scholar 

  22. Laviano A, Muscaritoli M, Cascino A et al (2005) Branched-chain amino acids: the best compromise to achieve anabolism? Curr Opin Clin Nutr Metab Care 8:408–414

    Article  CAS  Google Scholar 

  23. Layman DK (2003) The role of leucine in weight loss diets and glucose homeostasis. J Nutr 133:261S–267S

    Google Scholar 

  24. Mantovani G, Maccio A, Madeddu C et al (2006) A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress. Cancer Epidemiol Biomarkers Prev 15:1030–1034

    Article  CAS  Google Scholar 

  25. Mantovani G, Maccio A, Madeddu C et al (2001) Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites. J Mol Med 79:406–414

    Article  CAS  Google Scholar 

  26. Mantovani G, Maccio A, Mura L et al (2000) Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 78:554–561

    Article  CAS  Google Scholar 

  27. Mantovani G, Madeddu C, Maccio A et al (2004) Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. Cancer Epidemiol Biomarkers Prev 13:1651–1659

    CAS  Google Scholar 

  28. Marcora S, Lemmey A, Maddison P (2005) Dietary treatment of rheumatoid cachexia with beta-hydroxy-beta-methylbutyrate, glutamine and arginine: a randomised controlled trial. Clin Nutr 24:442–454

    Article  CAS  Google Scholar 

  29. May PE, Barber A, D’Olimpio JT, Hourihane A, Abumrad NN (2002) Reversal of cancer-related wasting using oral supplementation with a combination of beta-hydroxy-beta-methylbutyrate, arginine, and glutamine. Am J Surg 183:471–479

    Article  CAS  Google Scholar 

  30. Middleton N, Jelen P, Bell G (2004) Whole blood and mononuclear cell glutathione response to dietary whey protein supplementation in sedentary and trained male human subjects. Int J Food Sci Nutr 55:131–141

    Article  CAS  Google Scholar 

  31. Millward DJ, Rivers JP (1988) The nutritional role of indispensable amino acids and the metabolic basis for their requirements. Eur J Clin Nutr 42:367–393

    CAS  Google Scholar 

  32. Mosoni L, Houlier ML, Mirand PP, Bayle G, Grizard J (1993) Effect of amino acids alone or with insulin on muscle and liver protein synthesis in adult and old rats. Am J Physiol 264:E614–E620

    CAS  Google Scholar 

  33. Pasini E, Aquilani R, Dioguardi FS (2004) Amino acids: chemistry and metabolism in normal and hypercatabolic states. Am J Cardiol 93:3A–5A

    Article  CAS  Google Scholar 

  34. Pasini E, Aquilani R, Dioguardi FS, D’Antona G, Gheorghiade M, Taegtmeyer H (2008) Hypercatabolic syndrome: molecular basis and effects of nutritional supplements with amino acids. Am J Cardiol 101:11E–15E

    Article  CAS  Google Scholar 

  35. Pasini E, Aquilani R, Gheorghiade M, Dioguardi FS (2003) Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach. Ital Heart J 4:232–235

    Google Scholar 

  36. Patti ME, Brambilla E, Luzi L, Landaker EJ, Kahn CR (1998) Bidirectional modulation of insulin action by amino acids. J Clin Invest 101:1519–1529

    Article  CAS  Google Scholar 

  37. Platell C, Kong SE, McCauley R, Hall JC (2000) Branched-chain amino acids. J Gastroenterol Hepatol 15:706–717

    Article  CAS  Google Scholar 

  38. Rathmacher JA, Nissen S, Panton L et al (2004) Supplementation with a combination of beta-hydroxy-beta-methylbutyrate (HMB), arginine, and glutamine is safe and could improve hematological parameters. J Parenter Enteral Nutr 28:65–75

    Article  CAS  Google Scholar 

  39. Rothschild MA, Oratz M, Schreiber SS (1988) Serum albumin. Hepatology 8:385–401

    Article  CAS  Google Scholar 

  40. Solerte SB, Gazzaruso C, Bonacasa R et al (2008) Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia. Am J Cardiol 101:69E–77E

    Article  CAS  Google Scholar 

  41. Stein KD, Jacobsen PB, Blanchard CM, Thors C (2004) Further validation of the multidimensional fatigue symptom inventory-short form. J Pain Symptom Manage 27:14–23

    Article  Google Scholar 

  42. Stein KD, Martin SC, Hann DM, Jacobsen PB (1998) A multidimensional measure of fatigue for use with cancer patients. Cancer Pract 6:143–152

    Article  CAS  Google Scholar 

  43. Taegtmayer H (1994) Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol 19:59–113

    Google Scholar 

Download references

Acknowledgments

We thank Ms. Anna Rita Succa for her excellent technical assistance in editing the article.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giovanni Mantovani.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s12349-010-0027-6

About this article

Cite this article

Madeddu, C., Macciò, A., Astara, G. et al. Open phase II study on efficacy and safety of an oral amino acid functional cluster supplementation in cancer cachexia. Mediterr J Nutr Metab 3, 165–172 (2010). https://doi.org/10.1007/s12349-010-0016-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12349-010-0016-9

Keywords

Navigation